, Sweet, Starkey, Shekelle, 2013, p. 835). Depending on whether the patient is in early-stage vs. late-stage prognosis, the patient will be offered different treatments and approaches to managing the disease and its effects.
According to Qaseem et al., Stage 1 -- 3 CKD is treated in a variety of methods; different types of medicine, diets, exercise, and other treatments and approaches are all available, some with better results than others of course. Additionally, the problems with screening for CKD are often harbingers of problems that will crop up as the disease progresses. The Qaseem et al. study determined that "expert opinion suggests that the harms of CKD screening include misclassification of patients owing to false-positive test results, adverse effects of unnecessary testing, psychological effects of being labeled with CKD, adverse events associated with pharmacologic treatment changes after CKD diagnosis, and possible ?nancial rami-cations of CKD diagnosis" (p. 837). In other words, the diagnosis could be much worse than the disease itself.
The amount of data and the number of studies that have been completed regarding CKD is astounding; the extent of the disease is overwhelming. It is hoped that this study...
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet. 2011;377:2181-92. [PMID: 21663949]
Chou, C.Y.; Liang, C.C.; Kuo, H.L.; Chang, C.T.; Liu, J.H.; Lin, H.H.; Wang, I.K.; Yang, Y.F. Huang, C.C.; (2014) Comparing risk of new onset Diabetes Mellitus in Chronic Kidney Disease patients receiving Peritoneal Dialysis and Hemodialysis using propensity score matching, PLoS, Vol. 9, Issue 2, pp. 1 -- 6
Qaseem, A.; Hopkins, Jr., R.H.; Sweet, D.E.; Starkey, M.; Shekelle, P.; (2013) Screening, monitoring, and treatment of Stage 1 to 3 Chronic Kidney Disease: A clinical practice guideline from the American College of Physicians, Annals of Internal Medicine, Vol. 59, Issue 12, pp. 835-848
Tonelli, M. & Wanner, C.; (2014) Lipid management in Chronic Kidney Disease: Synopsis of the kidney disease: Improving global outcomes 2013 clinical practice…
